Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 10Prostatic Neoplasms 8Head and Neck Neoplasms 8Colorectal Neoplasms 8Breast Neoplasms 7Motor Activity 6Ovarian Neoplasms 5Rectal Neoplasms 4Oropharyngeal Neoplasms 4Multiple Myeloma 4Endometrial Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Hematologic Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3COVID-19 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Pancreatic Neoplasms 2Obesity 2Nasopharyngeal Neoplasms 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Leiomyoma 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Hematological Cancer 2Colonic Neoplasms 2Carcinoma, Squamous Cell 2

Interventions

recombinant interferon alpha 2b-like protein 1Thalidomide 1Temozolomide 1Tegafur 1Surveys and Questionnaires 1Phlebotomy 1Pancreatectomy 1Metformin 1Injections 1Everolimus 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Chromogranin A 1Biopsy, Large-Core Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenoma, Islet Cell × Surveys and Questionnaires × Clear all
NCT03043508 2019-05-23

Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)

M.D. Anderson Cancer Center

Unknown
45 enrolled

Adenoma, Islet Cell, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡